SERA Insider Trading
Insider Ownership Percentage: 15.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,668,928.82
Sera Prognostics Insider Trading History Chart
This chart shows the insider buying and selling history at Sera Prognostics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Sera Prognostics Share Price & Price History
Current Price: $3.25
Price Change: ▲ Price Increase of +0.14 (4.50%)
As of 04/11/2025 05:00 PM ET
Sera Prognostics Insider Trading History
Sera Prognostics Institutional Trading History
Data available starting January 2016
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Read More on Sera Prognostics
Volume
47,989 shs
Average Volume
131,807 shs
Market Capitalization
$122.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.96
Who are the company insiders with the largest holdings of Sera Prognostics?
Sera Prognostics' top insider shareholders include:
- Zhenya Lindgardt (CEO)
- Austin Aerts (CFO)
- Paul Kearney (Insider)
- John J Boniface (Insider)
- Benjamin Jackson (General Counsel)
- Robert Gardner Harrison (Insider)
- Mansoor Raza Mirza (Director)
- Joshua Phillips (Director)
Learn More about top insider investors at Sera Prognostics.
Who are the major institutional investors of Sera Prognostics?
Which major investors are buying Sera Prognostics stock?
In the previous quarter, SERA stock was acquired by institutional investors including:
- Rhumbline Advisers
- Sanders Morris Harris LLC